Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Entera Bio (ENTX) Long-Term Deferred Tax (2021 - 2024)

Entera Bio has reported Long-Term Deferred Tax over the past 4 years, most recently at $14000.0 for Q3 2024.

  • For the quarter ending Q3 2024, Long-Term Deferred Tax fell 6.67% year-over-year to $14000.0, compared with a TTM value of $14000.0 through Sep 2024, down 6.67%, and an annual FY2023 reading of $14000.0, down 67.44% over the prior year.
  • Long-Term Deferred Tax came in at $14000.0 for Q3 2024, roughly flat from $14000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $280000.0 in Q2 2022 to a low of $14000.0 in Q4 2023.
  • Median Long-Term Deferred Tax over the past 4 years was $43000.0 (2022), compared with a mean of $84416.7.
  • The sharpest move saw Long-Term Deferred Tax plummeted 84.64% in 2023, then decreased 6.67% in 2024.
  • Over 4 years, Long-Term Deferred Tax stood at $217000.0 in 2021, then crashed by 80.18% to $43000.0 in 2022, then tumbled by 67.44% to $14000.0 in 2023, then changed by 0.0% to $14000.0 in 2024.
  • Per Business Quant, the three most recent readings for ENTX's Long-Term Deferred Tax are $14000.0 (Q3 2024), $14000.0 (Q2 2024), and $14000.0 (Q1 2024).